Evaluation of Organized Human Papilloma Virus (HPV) Screening of 23-29-year-old Women
Evaluation of Organized Human Papilloma Virus (HPV) Screening of 23-29-year-old Women
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.
The aim is to investigate whether primary HPV analysis in the organized cell sampling program for women in the age group 23-29 provides higher cancer protection compared to the current method where cell samples are primarily analyzed with cytology. In this study, all women in the age group 23-29 in the Stockholm and Skåne Region of Sweden will participate. Age is defined by year of birth. For 2020, women born 1991-1997 are included. Sampling and collection of samples is the same as for cytology.
Inclusion Criteria:
Exclusion Criteria:
joakim.dillner@ki.se+46 (0) 72-468 24 60
miriam.elfstrom@ki.se+46 (0) 70-381 62 77